liu.seSearch for publications in DiVA
Change search
Link to record
Permanent link

Direct link
Laytragoon-Lewin, Nongnit
Publications (1 of 1) Show all publications
Oliva, D., Nilsson, M., Andersson, B.-Å., Sharp, L., Lewin, F. & Laytragoon-Lewin, N. (2017). Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer. Clinical and Translational Radiation Oncology, 2, 1-6
Open this publication in new window or tab >>Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer
Show others...
2017 (English)In: Clinical and Translational Radiation Oncology, ISSN 2405-6308, Vol. 2, p. 1-6Article in journal (Refereed) Published
Abstract [en]

Background Women receiving FEC (5 fluorouracil, epirubicin and cyclophosphamide) chemotherapy (CT) for breast cancer (BC) often experience side effects such as nausea and vomiting. Individual variations of side effects occur in patients despite similar cancer therapy. The purpose of this study was to investigate a possible genetic background as a predictor for individual variations in nausea induced by CT. Methods 114 women were included in the study. All women received adjuvant CT for BC. Self-reported nausea and vomiting was recorded in a structured diary over ten days following treatment. Blood samples were collected before the treatment and used for the detection of 48 single nucleotide polymorphisms (SNPs) in 43 genes. SNPs from each individual woman were analyzed for their relation to the patient-reported frequency and intensity of nausea and vomiting. Results Eighty-four percent (n=96) of the women reported acute or delayed nausea or combined nausea and vomiting during the ten days following CT. Three out of the forty-eight SNPs in the following genes: FAS/CD95, RB1/LPAR6 and CCL2 were found to be associated with a risk of nausea. Conclusion SNPs in the FAS/CD95, RB1/LPAR6 and CCL2 genes were found to be associated with nausea among women treated with adjuvant FEC for BC. SNPs analysis is fast and cost effective and can be done prior to any cancer therapy. The association between individual SNPs and severe side effects from FEC may contribute to a more personalized care of patients with BC.

Place, publisher, year, edition, pages
Elsevier, 2017
Single nucleotide polymorphisms, Chemotherapy, Nausea, Breast cancer
National Category
Nursing Cancer and Oncology
urn:nbn:se:liu:diva-162106 (URN)10.1016/j.ctro.2016.12.001 (DOI)
Available from: 2019-11-19 Created: 2019-11-19 Last updated: 2019-11-20Bibliographically approved

Search in DiVA

Show all publications